USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Technology Innovations and Growth Opportunities in Structural Heart Implants
Biomaterials and Design Advances Improve the Efficacy and Safety of Heart Valves and Occluders
19-Dec-2022
Global
Technology Research
DA75-01-00-00-00
HC03616-GL-TR_27280
Structural heart diseases (SHD) encompass cardiac conditions that cause abnormal blood flow inside the heart's chambers, which can be wrong blood flow direction or blood stagnation. Structural abnormalities in the heart lead to impaired functioning rather than the heart's blood vessels. The cardiovascular implants industry has developed prosthetic valves and occluders to repair structural cardiac defects. This research study analyzes technological innovations in transcatheter mitral valve replacement/repair (TMVr/TMVR) implants and atrial septal defect (ASD) occluders. These implants are evolving to become more biomimetic and intelligent with artificial intelligence (AI)-enabled deployers.
The report also covers the following:
• Industry trends
• Active R&D areas
• Emerging technologies
• Notable stakeholders
• Growth opportunities
Why Is It Increasingly Difficult to Grow?The Strategic Imperative 8™: Factors Creating Pressure on Growth
The Strategic Imperative 8™
The Impact of the Top 3 Strategic Imperatives on the Structural Heart Implants Industry
Growth Opportunities Fuel the Growth Pipeline Engine™
Research Methodology
SHD Overview
Most Prevalent
Most Well-established Interventional Technique for Valvular Heart Disease: Percutaneous Mitral Valvuloplasty (PTMV)
PTMV is the Most Well-established Structural Interventional Technique (continued)
PTMV is the Most Well-established Structural Interventional Technique (continued)
Structural Heart Implants Segmentation
Interventional Treatment—Mainly for Patients at Surgical Risk
Market Analysis of Technologies
Market Analysis of Technologies (continued)
Market Analysis of Technologies (continued)
Market Analysis of Technologies (continued)
Market Analysis of Technologies (continued)
Growth Drivers
Growth Restraints
Scope of Analysis
Preference to Mitral Valve Repair over Mitral Valve Replacement
Mitral Valve Material Analysis
Mitral Valve Material Analysis (continued)
Self-expanding Frame of the Valves Generally Comprises Nitinol
Most-adopted Design Intervention—Trileaflet Valve Comprising Pericardium in a Self-expanding Nitinol Frame
Most-adopted Design Intervention—Trileaflet Valve Comprising Pericardium in a Self-expanding Nitinol Frame (continued)
United States Has the Most Innovations in TMVr/TMVR
Tc-ASD can Treat ASD of Septum Secundum
ASD Material Analysis—Nitinol Wireframes Causing Erosion in Implanted Tc-ASD Devices
ASD Material Analysis—Nitinol Wireframes Causing Erosion in Implanted Tc-ASD Devices (continued)
Flexible Petal Design Ensures Less Friction Minimizing the Erosion
Gore Medical Tc-ASDs are FDA Approved and are the Most Successful
Tc-ASDs Geographical Analysis—United States Has the Most Innovations Dealing with Tc-ASDs
AI-enabled Prosthetic Mitral Valves as the Future of TMVR/TMVr
3D-bio-printed, Bio-inspired ASD Occluder is the Future
Structural Heart Implants for MIS
Need for Balancing Innovation and Regulation
Patent Database Analysis for TMVR/TMVr Industry
Patent Database Analysis for ASD Closure Devices
Emerging technology Analysis for Mitral Implants and ASD Occluders
Application of AI in Cardiovascular Implants in the Growth Phase
Growth Opportunity 1: Bio-inspired or Biomimetic Structural Heart Implants will Lead to Less Device Failure
Growth Opportunity 1: Bio-inspired or Biomimetic Structural Heart Implants will Lead to Less Device Failure (continued)
Growth Opportunity 2: Microelectronics and AI-enabled Smart Implants for Capturing Real-time Heart Parameters
Growth Opportunity 2: Microelectronics and AI-enabled Smart Implants for Capturing Real-time Heart Parameters (continued)
Growth Opportunity 3: Collaborative/In-house Development of Visualization Techniques with Cardiac Implants
Growth Opportunity 3: Collaborative/In-house Development of Visualization Techniques with Cardiac Implants (continued)
The Latest Patents Include AI and ML-enabled Intelligent Structural Heart Implants
Technology Readiness Levels (TRL): Explanation
Your Next Steps
Why Frost, Why Now?
Legal Disclaimer
Speak directly with our analytics experts for tailored recommendations.
Recent related Healthcare research
28 Oct 2026 | Global | Frost Radar
Frost Radar™: Health Monitoring Wearable Solutions, 2026
The health monitoring wearables industry is undergoing a profound transformation as competitive advantage shifts from device hardware to integrated digital health ecosystems. Market leaders are differentiating through clinically validated health insights, longitudinal data platforms, AI-enabled anal...
26 Oct 2026 | Global | Technology Research
Game-Changing Innovations Transforming Cardiovascular Care
The study analyzes game-changing technologies transforming cardiovascular care across diagnosis, image-guided intervention, functional assessment, clinical workflow, and longitudinal patient monitoring. The analysis covers five segments: diagnostic imaging and AI-enabled cardiac assessment; interve...
23 Oct 2026 | Global | Technology Research
Innovations and Growth Opportunities in Advanced Medical Devices, Implantable and Diagnostic Solutions
The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) spotlights a diverse slate of innovations across advanced medical devices, diagnostic solutions, and implantable.The issue features advanced medical devices such as single-breath-hold radiotherapy system, transcatheter system f...
16 Oct 2026 | Global | Market Research
Public Sector Healthcare Cloud Market, North America and Europe, 2026
Public healthcare organizations across North America and Europe are using cloud technologies to support modernization efforts that extend beyond infrastructure replacement. Cloud is increasingly being adopted to improve interoperability, enable secure data sharing, support analytics and AI initiativ...
16 Oct 2026 | Global | Technology Research
Innovations and Growth Opportunities in Precision Therapeutics, AI-Enabled Discovery and Bioengineering, Regenerative Medicine, and Next-Generation Vaccine Platforms
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations transforming precision therapeutics, regenerative medicine, AI-enabled discovery, laboratory automation, targeted delivery, vaccines, and biomanufactu...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.